_ensuring-viral-safety-in-cell-amp-gene-therapy-through-next-generation-sequencing-preview-1.jpg "Ensuring Viral Safety in Cell & Gene Therapy Through Next-Generation Sequencing from viral clearance for gene therapy products Video Screenshot Preview 1")
Gallery_ensuring-viral-safety-in-cell-amp-gene-therapy-through-next-generation-sequencing-preview-3.jpg "Ensuring Viral Safety in Cell & Gene Therapy Through Next-Generation Sequencing from viral clearance for gene therapy products Video Screenshot Preview 3")
Gallery_ensuring-viral-safety-in-cell-amp-gene-therapy-through-next-generation-sequencing-preview-hqdefault.jpg "Ensuring Viral Safety in Cell & Gene Therapy Through Next-Generation Sequencing from viral clearance for gene therapy products Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 56 minutes 54 seconds
👁 View: 42 times
Play Audio:👁 View: 42 times
Description:
BioProcess International
BioProcess International
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_basics-of-aav-gene-therapy.webp "ASGCT")
_the-current-landscape-of-viral-vector-based-gene-therapy.webp "VJRegenMed")
_viral-safety-by-design-for-cell-and-gene-therapy-products.webp "Biopharma Webinar Series")
_1-adeno-associated-virus-aav-an-introduction.webp "Applied Biological Materials - abm")
_clearing-the-way-for-viral-clearance.webp "BioProcess International")
_introduction-to-viral-safety-part-3-two-minute-tuesday-technical-training.webp "WuXi Biologics")
⏲ 3 minutes 28 seconds 👁 2.1K
_virus-removal-and-inactivation-in-the-monoclonal-antibody-process-mp4.webp "MilliporeSigma")
_measuring-quality-attributes-for-gene-therapies-empty-vs-full-viral-vector-capsids.webp "Catalent Pharma Solutions")
⏲ 2 minutes 12 seconds 👁 559
_basics-of-aav-gene-therapy.jpg)
_the-current-landscape-of-viral-vector-based-gene-therapy.jpg)
_viral-safety-by-design-for-cell-and-gene-therapy-products.jpg)
_1-adeno-associated-virus-aav-an-introduction.jpg)
_clearing-the-way-for-viral-clearance.jpg)
_introduction-to-viral-safety-part-3-two-minute-tuesday-technical-training.jpg)
_virus-removal-and-inactivation-in-the-monoclonal-antibody-process-mp4.jpg)
_measuring-quality-attributes-for-gene-therapies-empty-vs-full-viral-vector-capsids.jpg)
![[+]](/images/menu.gif){kind=small}